Last update 23 Jan 2025

MVR-T3011

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
T-3 - ImmVira Pharma, T3 oHSV
+ [5]
Mechanism
IL-12R stimulants(Interleukin-12 receptor stimulants), PD-1 inhibitors(Programmed cell death protein 1 inhibitors)
Active Indication
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (US), Orphan Drug (US)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 2
AU
17 Sep 2020
Metastatic melanomaPhase 2
US
17 Sep 2020
metastatic non-small cell lung cancerPhase 2
US
17 Sep 2020
metastatic non-small cell lung cancerPhase 2
AU
17 Sep 2020
Advanced Malignant Solid NeoplasmPhase 2
CN
10 Apr 2020
Breast CancerPhase 2
CN
10 Apr 2020
Esophageal CarcinomaPhase 2
CN
10 Apr 2020
Non-Small Cell Lung CancerDiscovery
CN
21 Apr 2020
SarcomaDiscovery
CN
21 Apr 2020
Squamous Cell Carcinoma of Head and NeckDiscovery
CN
21 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
(bvtykwusfy) = zfbetyxcdb lpxszvnrmj (amooteytha )
Positive
15 Sep 2024
(bvtykwusfy) = dpybszzzsy lpxszvnrmj (amooteytha )
Phase 1
18
(dsheaqiykl) = ewtwtrutkz dfytrsgkkd (eozopazxls )
Positive
09 Nov 2023
Phase 1/2
10
(yymkbkaswl) = rsyuwhripj frjtqrjgrd (tcrwrvkabm )
Positive
31 May 2023
Phase 1/2
90
(cazshgszkz) = vqbsieiyzt xhtzzyqpqx (pgctbzqhgq )
Positive
26 May 2023
Phase 1/2
15
(rlvzijemhl) = kffakyfxtd pfzsyxjdrz (czpupaeiez )
Positive
26 May 2023
Phase 1/2
29
(ncjmfpaeog) = 3.4% (1/29) wcshboqtaa (hstcgjokly )
Positive
26 May 2023
Phase 1
8
(cscksdgicx) = pain at injection site, leukopenia, anemia, hypocalcemia, nausea, fever, headache, dermatitis, and diaphoresis xteinokfja (ekqiaiuctr )
Positive
28 May 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free